| |
| |
|
| Insider
Information: |
Millar Kerri-Ann |
| Relationship: |
CHIEF FINANCIAL OFFICER |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,311 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$27,334 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,311 |
|
|
| Total
Value |
$27,334 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cue Biopharma, Inc. |
CUE |
CHIEF FINANCIAL OFFICER |
2022-08-22 |
14,311 |
2018-08-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-08-22 |
4 |
D |
$3.05 |
$8,625 |
D/D |
(2,828) |
14,311 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2022-08-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
17,139 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2021-10-01 |
4 |
OE |
$7.50 |
$9,383 |
D/D |
1,251 |
11,723 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2021-10-01 |
4 |
AS |
$14.21 |
$17,783 |
D/D |
(1,251) |
10,472 |
0 |
% |
|
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2021-08-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
12,433 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2021-08-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,961) |
10,472 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CFO |
• – – |
2020-08-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,900) |
5,766 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
CFO |
• – – |
2020-08-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
7,666 |
0 |
- |
|
| CUE |
Cue Biopharma, Inc. |
VP-Finance |
• – – |
2018-08-29 |
4 |
B |
$8.48 |
$8,480 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
